Scarica l'app Stockscreener
8.18
1.11%
0.09
Dopo l'orario di chiusura:
8.18
Precedente Chiudi:
$8.09
Aprire:
$8.12
Volume 24 ore:
238.16K
Relative Volume:
1.35
Capitalizzazione di mercato:
$306.47M
Reddito:
$128.45M
Utile/perdita netta:
$6.54M
Rapporto P/E:
163.60
EPS:
0.05
Flusso di cassa netto:
$-8.79M
1 W Prestazione:
-0.85%
1M Prestazione:
+3.54%
6M Prestazione:
+0.74%
1 anno Prestazione:
+10.09%
Intervallo 1D:
$7.985
$8.24
Intervallo di 1 settimana:
$7.88
$8.36
Portata 52W:
$4.76
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Nome
Lifecore Biomedical Inc
Settore
Telefono
(952) 368-4300
Indirizzo
3515 LYMAN BOULEVARD, CHASKA
Confronta LFCR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
8.18 | 303.10M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
125.82 | 55.71B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.59 | 49.38B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.11 | 44.89B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.21 | 35.96B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
487.25 | 21.36B | 3.08B | 1.24B | 1.07B | 25.61 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | Iniziato | William Blair | Outperform |
| 2024-09-05 | Iniziato | Craig Hallum | Buy |
| 2024-08-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie
Lifecore Biomedical: The Turnaround Is Just Getting Started (NASDAQ:LFCR) - Seeking Alpha
Important Notice to Long-Term Shareholders of CarMax, Inc. - GlobeNewswire
Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement - TMX Newsfile
KeyBanc maintains Sector Weight rating on Lifecore Biomedical stock By Investing.com - Investing.com UK
LFCR Deadline: LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit - GuruFocus
(LFCR) Volatility Zones as Tactical Triggers - Stock Traders Daily
EBIT per share of Lifecore Biomedical, Inc. – DUS:LDE - TradingView — Track All Markets
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
Lifecore Biomedical, Inc.(NasdaqGS: LFCR) added to NASDAQ Biotechnology Index - marketscreener.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Lifecore Biomedical Inc. stock overvalued by current metricsJuly 2025 Spike Watch & Technical Pattern Recognition Alerts - Улправда
Is Lifecore Biomedical Inc. stock positioned for long term growthJuly 2025 Sector Moves & Community Verified Watchlist Alerts - Улправда
How sustainable is Lifecore Biomedical Inc. stock dividend payout2025 Historical Comparison & Fast Moving Trade Plans - Улправда
One Lifecore Biomedical Insider Raised Their Stake In The Previous Year - Yahoo Finance
Can Lifecore Biomedical Inc. stock maintain operating marginsMarket Performance Recap & AI Enhanced Trade Execution Alerts - Улправда
Support Test: Is Lifecore Biomedical Inc. stock vulnerable to regulatory risksWeekly Trend Report & AI Based Buy/Sell Signal Reports - Улправда
Can Lifecore Biomedical Inc. (LDE) stock deliver strong annual returnsEarnings Overview Report & Daily Stock Trend Watchlist - ulpravda.ru
Can Lifecore Biomedical Inc. stock maintain growth trajectoryCEO Change & Real-Time Buy Signal Alerts - DonanımHaber
Is Lifecore Biomedical Inc. stock dividend yield sustainableJuly 2025 Short Interest & Trade Opportunity Analysis Reports - DonanımHaber
Can Lifecore Biomedical Inc. stock resist sector downturnsDollar Strength & Verified High Yield Trade Plans - DonanımHaber
How institutional buying supports Lifecore Biomedical Inc. stockTreasury Yields & AI Forecast for Swing Trade Picks - Bölüm Sonu Canavarı
Investment Report: Is Lifecore Biomedical Inc. stock overvalued by current metricsQuarterly Performance Summary & AI Powered Market Entry Strategies - Улправда
Lifecore Biomedical to Join Nasdaq Biotech Index - marketscreener.com
Lifecore Biomedical to be Added to Nasdaq Biotech Index - The Manila Times
Is Lifecore Biomedical Inc. stock vulnerable to regulatory risksJuly 2025 WrapUp & Consistent Return Investment Signals - Улправда
Lifecore signs CDMO agreement with global pharma company By Investing.com - Investing.com Nigeria
Entry Recap: Why Lifecore Biomedical Inc. stock is favored by top institutionsWeekly Trade Report & Weekly Momentum Picks - moha.gov.vn
Lifecore Biomedical, Inc. Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer - marketscreener.com
Lifecore signs CDMO agreement with global pharma company - Investing.com India
Lifecore Biomedical Signs Agreement for Injectable Pharmaceutical Development Services with Major Global Partner - Quiver Quantitative
Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer - Sahm
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect - ACCESS Newswire
Keybanc Initiates Coverage of Lifecore Biomedical (LFCR) with Sector Weight Recommendation - MSN
Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com
Understanding the Setup: (LFCR) and Scalable Risk - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
What analysts say about Lifecore Biomedical Inc LDE stockFederal Reserve Announcements & Outperform the Market with Aggressive Picks - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Is Lifecore Biomedical Inc a good long term investmentMarket Sentiment Report & High Yield Stock Picks - earlytimes.in
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights - The AI Journal
Will Lifecore Biomedical Inc. (LDE) stock see insider accumulationWeekly Risk Report & Community Consensus Trade Signals - Newser
Will Lifecore Biomedical Inc. (LDE) stock attract long term capital inflowsWall Street Watch & Accurate Entry/Exit Alerts - Newser
The Technical Signals Behind (LFCR) That Institutions Follow - news.stocktradersdaily.com
Will Lifecore Biomedical Inc. (LDE) stock split increase liquidityMarket Risk Summary & Reliable Intraday Trade Alerts - Newser
Will Lifecore Biomedical Inc. (LDE) stock benefit from sector leadership - Newser
Will Lifecore Biomedical Inc. (LDE) stock keep raising dividendsBreakout Watch & Daily Stock Trend Watchlist - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - ACCESS Newswire
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirt - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Reach Out - ACCESS Newswire
Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
8.30%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):